Latest Breaking News On - American association of hematology annual meeting - Page 1 : comparemela.com

Incyte Announces U S Food and Drug Administration Grants Priority Review for Axatilimab for the Treatment of Chronic Graft-Versus-Host Disease

Incyte Announces U S Food and Drug Administration Grants Priority Review for Axatilimab for the Treatment of Chronic Graft-Versus-Host Disease
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesAmerican association of hematology annual meetingExchange commissionAmerican society of hematology annual meetingSyndax pharmaceuticals nasdaqDrug administrationPriority reviewBiologics license applicationPrescription drug user fee actPlenary scientific sessionAmerican societyHematology annual meetingSyndax pharmaceuticalsChief executive officerAmerican associationOrphan drug designation

Incyte Announces U S Food and Drug Administration Grants Priority Review for Axatilimab for the Treatment of Chronic Graft-Versus-Host Disease

- Priority Review acceptance based on positive results of AGAVE-201 study .

United statesAmerican association of hematology annual meetingSyndax pharmaceuticals nasdaqExchange commissionAmerican society of hematology annual meetingDrug administrationPriority reviewBiologics license applicationPrescription drug user fee actPlenary scientific sessionAmerican societyHematology annual meetingSyndax pharmaceuticalsChief executive officerAmerican associationOrphan drug designation

Incyte Announces U S Food and Drug Administration Grants Priority Review for Axatilimab for the Treatment of Chronic Graft-Versus-Host Disease

Incyte today announced that the U.S. Food and Drug Administration (FDA) has accepted for Priority Review the Biologics License Application (BLA) for axatilimab, an anti-CSF-1R antibody, for the treatment of chronic graft-versus-host disease (GVHD).

United statesDrug administrationAmerican society of hematology annual meetingAmerican association of hematology annual meetingProduct serviceExchange commissionSyndax pharmaceuticals nasdaqDrug administration grants priority review for axatilimabDrug administration grants priority reviewChronic graft versus hostPriority reviewBiologics license applicationPrescription drug user fee actPlenary scientific sessionAmerican societyHematology annual meeting